Pasin Laura, Febres Daniela, Testa Valentina, Frati Elena, Borghi Giovanni, Landoni Giovanni, Zangrillo Alberto
Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Paediatr Anaesth. 2015 May;25(5):468-76. doi: 10.1111/pan.12587. Epub 2015 Jan 6.
The preoperative period is a stressing occurrence for most people undergoing surgery, in particular children. Approximately 50-75% of children undergoing surgery develop anxiety which is associated with distress on emergence from anesthesia and with later postoperative behavioral problems. Premedication, commonly performed with benzodiazepines, reduces preoperative anxiety, facilitates separation from parents, and promotes acceptance of mask induction. Dexmedetomidine is a highly selective α2 -agonist with sedative and analgesic properties. A meta-analysis of all randomized controlled trials (RCTs) on dexmedetomidine versus midazolam was performed to evaluate its efficacy in improving perioperative sedation and analgesia, and in reducing postoperative agitation when used as a preanesthetic medication in children.
Studies were independently searched in PubMed, BioMedCentral, Embase, and the Cochrane Central Register of clinical trials and updated on August 15th, 2014. Primary outcomes were represented by improved sedation at separation from parents, at induction of anesthesia, and reduction in postoperative agitation. Secondary outcomes were reduction in rescue analgesic drugs, and duration of surgery and anesthesia. Inclusion criteria were random allocation to treatment and comparison between dexmedetomidine and midazolam. Exclusion criteria were adult studies, duplicate publications, intravenous administration, and no data on main outcomes.
Data from 1033 children in 13 randomized trials were analyzed. Overall, in the dexmedetomidine group there was a higher incidence of satisfactory sedation at separation from parents (314 of 424 [74%] in the dexmedetomidine group vs 196 of 391 [50%] in the midazolam group, RR = 1.30 [1.05-1.62], P = 0.02), a reduced incidence of postoperative agitation (14 of 140 [10%] vs 56 of 141 [40%], RR = 0.31 [0.13-0.73], P = 0.008), and a significant reduction in the rescue doses of analgesic drugs (49 of 241 [20%] vs 95 of 243 [39%], RR = 0.52 [0.39-0.70], P < 0.001). There was no evidence of a higher incidence of satisfactory sedation at anesthesia induction or any reduction of duration of surgery and anesthesia.
Dexmedetomidine is effective in decreasing anxiety upon separation from parents, decreasing postoperative agitation, and providing more effective postoperative analgesia when compared with midazolam.
术前阶段对大多数接受手术的人来说,尤其是儿童,是一段充满压力的时期。大约50%-75%接受手术的儿童会出现焦虑,这与麻醉苏醒时的痛苦以及术后行为问题有关。术前用药通常使用苯二氮卓类药物,可减轻术前焦虑,便于与父母分离,并促进患儿接受面罩诱导麻醉。右美托咪定是一种具有镇静和镇痛特性的高选择性α2受体激动剂。我们对所有关于右美托咪定与咪达唑仑对比的随机对照试验(RCT)进行了荟萃分析,以评估其作为儿童麻醉前用药时,在改善围手术期镇静和镇痛以及减少术后躁动方面的疗效。
在PubMed、BioMedCentral、Embase以及Cochrane临床试验中心注册库中独立检索研究,并于2014年8月15日进行更新。主要结局指标包括与父母分离时、麻醉诱导时镇静改善情况以及术后躁动减少情况。次要结局指标包括急救镇痛药用量减少、手术及麻醉持续时间。纳入标准为随机分配至治疗组以及右美托咪定与咪达唑仑的对比研究。排除标准为成人研究、重复发表、静脉给药以及无主要结局指标数据。
分析了13项随机试验中1033名儿童的数据。总体而言,右美托咪定组与父母分离时镇静满意的发生率更高(右美托咪定组424例中有314例[74%],咪达唑仑组391例中有196例[50%],RR = 1.30[1.05 - 1.62],P = 0.02),术后躁动发生率降低(140例中有14例[10%],141例中有56例[40%],RR = 0.31[0.13 - 0.73],P = 0.008),且急救镇痛药剂量显著减少(241例中有49例[20%],243例中有95例[39%],RR = 0.52[0.39 - 0.70],P < 0.001)。没有证据表明麻醉诱导时镇静满意的发生率更高,也没有证据表明手术及麻醉持续时间有任何缩短。
与咪达唑仑相比,右美托咪定在减少与父母分离时的焦虑、降低术后躁动以及提供更有效的术后镇痛方面有效。